These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18353766)

  • 1. Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
    Xun Z; Sowell RA; Kaufman TC; Clemmer DE
    Mol Cell Proteomics; 2008 Jul; 7(7):1191-203. PubMed ID: 18353766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease.
    Xun Z; Kaufman TC; Clemmer DE
    J Proteome Res; 2008 Sep; 7(9):3911-21. PubMed ID: 18683964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifetime proteomic profiling of an A30P alpha-synuclein Drosophila model of Parkinson's disease.
    Xun Z; Sowell RA; Kaufman TC; Clemmer DE
    J Proteome Res; 2007 Sep; 6(9):3729-38. PubMed ID: 17683129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila.
    Zhu ZJ; Wu KC; Yung WH; Qian ZM; Ke Y
    Biochim Biophys Acta; 2016 Apr; 1862(4):518-525. PubMed ID: 26769358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein expression in a Drosophila model of Parkinson's disease.
    Xun Z; Sowell RA; Kaufman TC; Clemmer DE
    J Proteome Res; 2007 Jan; 6(1):348-57. PubMed ID: 17203978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of wild-type and A53T mutant isoform of alpha-synuclein on the mitochondrial proteome of differentiated SH-SY5Y cells.
    Pennington K; Peng J; Hung CC; Banks RE; Robinson PA
    J Proteome Res; 2010 May; 9(5):2390-401. PubMed ID: 20334438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable isotope labeling and label-free proteomics of Drosophila parkin null mutants.
    Xun Z; Kaufman TC; Clemmer DE
    J Proteome Res; 2009 Oct; 8(10):4500-10. PubMed ID: 19705877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomics in A30P*A53T α-synuclein transgenic mice reveals upregulation of Sel1l.
    Yan J; Zhang P; Jiao F; Wang Q; He F; Zhang Q; Zhang Z; Lv Z; Peng X; Cai H; Tian B
    PLoS One; 2017; 12(8):e0182092. PubMed ID: 28771510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α-Synuclein-Based Mouse Models of Parkinson's Disease.
    Ma SX; Seo BA; Kim D; Xiong Y; Kwon SH; Brahmachari S; Kim S; Kam TI; Nirujogi RS; Kwon SH; Dawson VL; Dawson TM; Pandey A; Na CH; Ko HS
    J Proteome Res; 2021 Jul; 20(7):3428-3443. PubMed ID: 34061533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
    Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
    PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicity.
    Butler EK; Voigt A; Lutz AK; Toegel JP; Gerhardt E; Karsten P; Falkenburger B; Reinartz A; Winklhofer KF; Schulz JB
    PLoS Genet; 2012 Feb; 8(2):e1002488. PubMed ID: 22319455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
    Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease.
    Varga SJ; Qi C; Podolsky E; Lee D
    Brain Res; 2014 Oct; 1583():277-86. PubMed ID: 25130663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the
    Golomidov IM; Latypova EM; Ryabova EV; Bolshakova OI; Komissarov AE; Sarantseva SV
    J Neurogenet; 2022 Mar; 36(1):1-10. PubMed ID: 35467466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson's Disease.
    He F; Qi G; Zhang Q; Cai H; Li T; Li M; Zhang Q; Chen J; Ming J; Tian B; Zhang P
    Cell Mol Neurobiol; 2020 Aug; 40(6):897-909. PubMed ID: 32016637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.
    Wang W; Song N; Jia F; Tang T; Bao W; Zuo C; Xie J; Jiang H
    Neurochem Int; 2018 Mar; 114():71-79. PubMed ID: 29355568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study.
    Dumitriu A; Pacheco CD; Wilk JB; Strathearn KE; Latourelle JC; Goldwurm S; Pezzoli G; Rochet JC; Lindquist S; Myers RH
    Hum Mol Genet; 2011 Apr; 20(8):1478-87. PubMed ID: 21258085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.